Valley Fever, a fungal respiratory infection, dramatically increased in several southwestern states from 1998 through 2011, according to a new study by the Centers for Disease Control and Prevention. Cases in Arizona, California, Nevada, New Mexico and Utah rose from 2,265 in 1998 to more than 22,000 in 2011.
Valley Fever (Coccidioidomycosis) is caused by inhaling a fungus called Coccidioides, which lives in the soil in the southwestern United States. Not everyone who is exposed to the fungus gets sick, but those who do typically have flu-like symptoms that can last for weeks or months. More than 40 percent of patients who get ill from Valley Fever may require hospitalization at some point, with an average cost of nearly $50,000 per hospital visit. Previous studies have shown that, of those who get sick, nearly 75 percent miss work or school for approximately two weeks.
Valley Fever is causing real health problems for many people living in the southwestern United States, says CDC director Tom Frieden, MD, MPH. Because fungus particles spread through the air, its nearly impossible to completely avoid exposure to this fungus in these hardest-hit states. Its important that people be aware of Valley Fever if they live in or have travelled to the southwest United States.
This recent increase in Valley Fever could be related to changes in weather, which could impact where the fungus grows and how much of it is circulating; higher numbers of new residents; or changes in the way the disease is detected and reported to the states or CDC. More research is needed to understand why the number of reported cases of Valley Fever has increased. Between 1998 and 2011, Arizona and California had average increases in Valley Fever incidence of 16 and 13 percent per year, respectively. The CDC has provided grants to these two states to study Valley Fever.
During this time period, nearly 112,000 cases of Valley Fever were reported from 28 states and Washington, D.C., but 66 percent of cases were in Arizona, 31 percent were in California, 1 percent were in Nevada, New Mexico, and Utah, and about 1 percent were in all other states combined.
Its difficult to say whats causing the increase, says Benjamin J. Park, MD, chief epidemiologist with CDCs Mycotic Diseases Branch. This is a serious and costly disease and more research is needed on how to reduce its effects.
Doctors and patients should know that the symptoms of Valley Fever are very similar to flu or pneumonia symptoms and a lab test is the only way to tell if an illness is Valley Fever or not. Not everyone who gets Valley Fever needs treatment, but for people at risk for the more severe forms of the disease, early diagnosis and treatment is important. The best way to treat Valley Fever still needs to be studied, especially with the number of cases continuing to rise.
The study released Thursday was based on reporting of Valley Fever to the National Notifiable Disease Surveillance System. Many states collect and report case counts to CDC through this surveillance system.
For more information on Valley Fever, visit: http://www.cdc.gov/fungal/coccidioidomycosis
Â
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.